Post-Subcision Hyperpigmentation: Clinical Management and Treatment
Objectives: To present effective clinical strategies for managing post-subcision hyperpigmentation, particularly hemosiderin-induced and post-inflammatory cases. This session aims to provide medical colleagues with practical tools for early prevention, multimodal treatments, and case-based protocols to improve outcomes and reduce patient dissatisfaction following cellulite subcision procedures.
Introduction: Post-subcision hyperpigmentation is a common concern in aesthetic dermatology, especially in patients with prolonged bruising. Hemosiderin staining and post-inflammatory pigmentation may persist for months. Understanding the pathophysiology and risk factors is essential to optimize prevention and implement individualized treatment plans.
Materials / method: This presentation is based on clinical experience from over 300 subcision cases treated for cellulite. A protocol combining preventive oral tranexamic acid, early carboxytherapy, topical depigmenting agents, microneedling with drug delivery, and selective laser technologies was implemented. Cases of chronic pigmentation received targeted escalation with thioglycolic acid and picosecond laser.
Results: Over 80% of patients showed partial or complete improvement of pigmentation within 3 to 6 months. Early intervention and adherence to the combined protocol significantly reduced chronic pigmentation. Persistent cases responded well to individualized escalation therapy, with minimal adverse effects. Patient satisfaction improved notably with proactive pigment management.
Conclusion: Post-subcision pigmentation can be effectively managed through multimodal, protocol-driven care. Early intervention, combined with proper patient selection and ongoing monitoring, enhances treatment success. Clinical outcomes reinforce the importance of personalized strategies that integrate topical, systemic, and energy-based therapies to address pigmentation at different depths and etiologies.
